Comments on: High-dose-rate interstitial brachytherapy as monotherapy in one fraction of 20.5 Gy for the treatment of localize prostate cancer: toxicity and 6-years biochemical results.

Published

Journal Article (Letter)

Full Text

Duke Authors

Cited Authors

  • Lee, WR

Published Date

  • May 2019

Published In

Volume / Issue

  • 18 / 3

Start / End Page

  • 426 -

PubMed ID

  • 30797697

Pubmed Central ID

  • 30797697

Electronic International Standard Serial Number (EISSN)

  • 1873-1449

Digital Object Identifier (DOI)

  • 10.1016/j.brachy.2019.01.009

Language

  • eng

Conference Location

  • United States